Overexpression of the gene APP is implicated in the “amyloid cascade”, related to the pathogenesis of Alzheimer disease (AD) affecting approximately 20% of persons with DS beyond 40 years of age, 40% beyond 50 years, 80% and more beyond 60 years [28]. Here, APP is linked to Alzheimer disease.